Retinal Stem Cells for Transplant in a Glaucoma Model
About the Research Project
Program
Award Type
Standard
Award Amount
$90,000
Active Dates
April 01, 2006 - March 31, 2008
Grant ID
G2006032
Acknowledgement
Summary
In patients with glaucoma, vision is lost because of the death of nerve cells in the eye called retinal ganglion cells. Although treatments exist for glaucoma, many patients still lose vision because of the continued loss of retinal ganglion cells. It is well recognized that stem cells offer hope for the treatment of many diseases. Dr. van der Kooy’s laboratory was the first to describe the isolation of retinal stem cells from adult human and adult mouse eyes. When these stem cells are transplanted into mice, they have the remarkable capacity to integrate into the host retina. Furthermore, retinal stem cells can form all the major cell types that are found in the retina, including retinal ganglion cells. Dr. van der Kooy plans to transplant adult mouse retinal stem cells into the eyes of mice that have glaucoma and see whether these cells can replace lost retinal ganglion cells. This research will lead towards a day when it will be possible to take just a few retinal stem cells from a patient’s eye, expand their numbers in the lab, and then return them to that same patient in order to treat glaucoma.
Related Grants
National Glaucoma Research
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
National Glaucoma Research
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute
National Glaucoma Research
Interleukin-10 As a Neuroprotective Factor in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Tatjana Jakobs, MD
Current Organization
The Schepens Eye Research Institute, Mass. Eye and Ear
Interleukin-10 As a Neuroprotective Factor in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Tatjana Jakobs, MD
Current Organization
The Schepens Eye Research Institute, Mass. Eye and Ear